Literature DB >> 26157718

A study of professional radiation hazards in CT scan and nuclear medicine workers using GTG-banding and solid stain.

Vahid Changizi1, Mohammad Hossein Alizadeh2, Akbar Mousavi3.   

Abstract

BACKGROUND: CT scan and nuclear medicine exams deliver a great part of medical exposures. This study examined professional radiation hazards in CT scan and nuclear medicine workers.
METHODS: In a cross sectional study 30 occupationally exposed workers and 7 controls (all from personnel of a laboratory) were selected. Physical dosimetry was performed for exposed workers. Blood samples were obtained from the experimental and control groups. Three culture mediums for each one were prepared in due to routine chromosome analysis using G-banding and solid stain.
RESULTS: There were significant increased incidence of chromatid gap (ctg) and chromatid break (ctb) with mean±SD frequencies of 3±0.84 and 3.1±1.40 per 100 cells respectively in the nuclear medicine workers versus controls with mean±SD frequencies of 1.9±0.69 and 1.3±0.84 for ctg and ctb, respectively. Chromosome gaps (chrg) were higher significantly in the nuclear medicine population (2.47±0.91) than in controls (1.4±0.9) (p< 0.05). In CT scan group the ctg and ctb were increased with a mean±SD frequency of 2.7±0.79 and 2.6±0.91 per 100 cells respectively compared with control group. The mean±SD frequencies of the chrb were 2.0±0.75 and 0.86±0.690 per 100 cells for exposed workers and control group, respectively.
CONCLUSION: This study showed chromosome aberrations in peripheral lymphocytes using solid stain method are reasonable biomarker reflecting personnel radiation damage.

Entities:  

Keywords:  CT scan; Chromosome aberration; G-banding; Nuclear physics; Solid stain

Year:  2015        PMID: 26157718      PMCID: PMC4476214     

Source DB:  PubMed          Journal:  Med J Islam Repub Iran        ISSN: 1016-1430


Introduction

Humans are being exposed by natural ionizing radiation sources such as soil, air, building materials, cosmic irradiation and even body elements. Besides, anybody may have artificial irradiation experiences.[1]United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) has reported that mine workers, medical personnel in radiology, radiotherapy and nuclear medicine fields are highly at risk of receiving low doses of ionizing irradiations in long terms (2,3). Nowadays artificial rays have wide uses for medical diagnostic and therapeutic processes. Therefore they are the most important factors in society exposures (4,5). Ionizing radiations are power clastogen causing phosphodiester break in DNA (6). The other important side effects of absorbing ionizing irradiation is double strand break (DSB) forming chromosome aberrations (CAs). CASare important biomarkers for biological dosimetry. People with increase of CAS in peripheral blood lymphocytes (PBLS) are at high risks for cancer (7,8). Computed tomography scan (CT scan) and nuclear medicine exams deliver a great part of medical exposures. Nuclear medicine uses radioisotopes for diagnostic and therapeutic cases through oral or injection. Radioisotopes decay and their irradiation expose to patient, his family and nuclear medicine personnel. It is low doses in diagnostic exams. Personnel are being exposed during transport of drug, injection to patient, and generator milking for many years (9).Professional radiation workers are under long term exposures. In radiology ward multislice computed tomography technique has a wide spectrum of uses. However it uses high radiation doses. International Commission on Radiological Protection (ICRP) has reported organ doses in CT scan. It is close to that of atomic bombardment remainders (10). According to above explanations we decided to study chromosome aberrations and effective dose in CT scan among nuclear medicine personnel. Besides, we compared chromosome response to clastogen medium between these exposed personnel and ordinary people.

Methods

Subjects

In a cross-sectional study, occupationally exposed workers were 30 technicians of CTscan and nuclear medicine (all personnel and 7 individuals from the hospital administrative staffs with no exposure history as the control group. This study was confirmed by the University Committee of Ethics. Every person was informed of the study aims and procedures and written consent form was obtained from all participants. All of them were in healthy conditions at the time of exam. Occupationally exposed workers were classified in two groups of CT scan and nuclear medicine. CT scan group included 15 people (10 (67%) men and 5 (33%) women) with mean±SD age of 37±7.34 years (rang: 24-49 years). Also nuclear medicine group included 15 people with mean±SD age of 35.4±9.24 years (range: 22-54 years). In this study only diagnostic nuclear medicine workers were considered. Table 1 shows characteristics of participants.
Table 1

Characteristics of study participants.

ParameterExposed subjectControl
Nuclear medicineCT scan
Number of individual15157
Age(year)(Mean ± SD)Rage 35.4±9.2422-54) 37 ± 7.34(24-49) 33.7 ± 5.34(25-40)
GenderMale % Female % 60%40% 36.733. 42.9%57.1%
Smoking statusNon-smokersSmokers 32 150 61
Duration of exposure(year)(Mean ± SD)Range 6.6 ± 5.13(1-15) 12.4 ± 7.08(1-26) 00
Family history of cancer000
The mean±SD work experiences for CT scan and nuclear medicine groups were 12.4±7.08 (range: 1-15 years) and 6.6±5.13 years (range: 1-15 years), respectively. All of them were working 44 hours/week.

Physical dosimetry

Physical dosimetry was done for every one by film badge. Total dose was acquired for every two months and for 6 periods before blood sampling. With this dosimetry total effective dose, Hp (10) and skin dose, Hp(0.07) are assessable.

Blood sampling

After the last period of dosimetry, blood sampling was performed in two steps under sterile conditions. In each step 5 ml peripheral blood was obtained by 10ml syringe and maintained in heparin tube (mediplus lithium heparin). Sampling was performed for experimental and control groups at the same time. All samples were coded randomly and under reasonable thermal condition of 40C-200C up 10 hours were transferred to the cell culture laboratory by coolant pack for instant cell culture.

Lymphocytes culture

Three culture mediums for each one were prepared as follows: For routine chromosome analysis using G-banding and solid stain For chromosome breakage study using mitomycin - c (mmc) Storage culture medium Whole blood cultures were created by adding 0.5ml heparinized whole blood into 4ml of RPMI 1640 medium (Gibco company production), supplemented with 1 phytohemaglutinin (PHA), 20 fetal bovine serum (FBS), antibiotics (penicillin100/ml and streptomycin 100µg/ml). All cultures were incubated in a CO2 incubator. To arrest dividing lymphocytes in metaphase, colchicine at a concentration of 0.5mg/ml, 2 hours prior harvest was added to the culture. After 48 hours incubation the culture were centrifuged at 1000rpm for 10 min. The supernant was removed. Remaining cells were resuspended in a hypotonic solution of KCl (0.075), incubated for 20 min at 37oC incubator. In next step centrifugation was performed for 5min at 1000 rpm and the cell were fixed with three exchanges of solution of a fresh mixture of methanol: acetic acid (3:1). The cell suspensions were dropped from 15-20 cm height onto wet, cold slides and blindly left to air dry. All slides were coded and grouped in two equal groups. For the first group’s slides staining was performed using Gimsa 5 (Sigma) for 5min. Then metaphase and chromosome analysis were carried out. For the second group’s slides, G-banding was performed by tripsine-pbs at 37oC for 40 -45 sec. Then slides were coded and subjected to 5% Giemsa. The slides were washed and considered for metaphase and chromosome analysis. To study the effect of mitomycin-c as a clastogen 24 hours after the cell culture, 10 ʎ mitomycin-c (mmc) was added to the cultures at a final concentration of 20µgr/ml. Colchicine of 10µgr/ml was added to the cultures, 2 hours prior to the harvest. The cultures were centrifuged at 1000 rpm for 10 minute, the supernatant was removed. The remaining cells were treated by a 3-4 cc hypotonic solution of 0.075 mol/lit KCl, incubated for 20 minute at 37 oC. The cells were fixed with a fresh mixture of 6 methanols: acetic acid (3:1). Similar to without mitomycin-c approach centrifugation and resuspension were carried out three times and then the cells transferred onto wet, cold slides. The slides were coded and staining was performed by 5% Giemsa (Sigma). The frequency of CAS in the lymphocytes of the exposed and control groups and that of two exposed groups were compared using Fisher’s exact test. The influence of age, work experience with radiation and annually effective dose on the CAS were tested by Pearson correlation. The influence of sex was tested by the independent test. Statistical evaluations were done byFisher’s exact test using SPSS v.21 software.

Results

Demographic characteristics of control and exposed personnel are listed in Table 1. These groups did not significantly differ in age, sex and smoking habits (p>0.05). Family history of cancer was not reported in three studied groups. Mean±SD of occupationally annual effective doses for nuclear medicine and CT scan groups were 1.4±2.3 mSv (range: 0.05-8.99 mSv) and 0.007±0.01 mSv (range: 0-0.06 mSv) respectively. This value for nuclear medicine workers was significantly higher than that for CT scan workers (p<0.05). Mean frequencies of chromosome aberrations for three populations (with and without mitomycin-c) are shown in Tables 2 and 3. Nuclear medicine population had the highest CAS among the three groups.
Table 2

Frequency of aberrant cells without mmc in lymphocytes of exposed workers and controls

GroupSample size NoOf cellscored Totalaberrant cell ChromatidgapN (Mean ± S.D‏) chromatidbreaks‏(Mean ± S.D‏) ChromosomeGaps‏(Mean ± S.D‏) chromosomebreaks‏(Mean ± S.D‏) Fragments‏(Mean ± S.D‏) Rearrangement‏(Mean ± S.D‏)
Control77003713(1.86±0.69‏)9(1.29±0.84‏)8 (1.4±0.90‏)6 (0.86±0.69‏)1 (0.29±0.48‏) 00
Nuclear medicine151500169 45‏ (3±0.84‏) 47 (3.13±1.40‏)36(2.47±0.91‏)36 (2.20±0.86‏)6 (0.4±0.7‏) 2(0.13±0.35‏)
Ct scan15150014641(2.73±0.79‏)39 (2.6±0.79‏)32 (2.07±1.03‏)30 (2±0.75‏)3 (0.2±0.56‏) 1 (0.07±0.25‏)
Table 3

Frequency of aberrant cells with mmc in lymphocytes of exposed workers and controls

GroupSample size No.of cellscored Totalaberrant cell ChromatidGapN (Mean ± S.D) ChromatidbreaksN ( Mean ± S.D) ChromosomeGapsN (Mean ± S.D) chromosomebreaksN (Mean ± S.D) FragmentsN (Mean ± S.D) RearrangementN (Mean ± S.D)
Control770027381 (11.5±0.97)77 (11±1.4) 54(7.7±1.7) 54 (7.7±0.75)5 (0.71±0.75)2 (0.29±0.48)
Nuclear medicine151500683211 (13.8±2.8)180 (12±3.04)127 (8.4±1.9)144 (9.6±1.6) 15 (1±1.1) 6(0.4±0.5)
Ct scan151500630190 (13.47±1.76)167 (11.1±2.3)119 (7.9±2.5)137 (9.1±1.8)13 (0.87±1.06) 4(027± 0.45)
There were significant increased incidence of chromatid gap (chg) and chromatid break (chb) with mean±SD frequencies of 3±0.84 per 100 cells and 3.1±1.40 per 100 cells respectively in the nuclear medicine workers versus controls with a mean±SD frequency of 1.86±0.69 and 1.29±0.84 for chg and chb respectively. P-values for these comparisons were 0.05 and 0.06 respectively. Chromosome gap (chrg) and chromosome breaks (chrb) were higher in the nuclear medicine group (2.47±0.91 and 2.2±0.86 respectively) than in controls (1.4±0.9 and 2.2±0.86 respectively). These increases were significant for chrg (p<0.) and on the borderline for chrb (p=0.08). In this group fragment (F) and rearrangement (r) were greater than those in controls with mean±SD frequencies of 0.4±0.7 and 0.13±0.35 versus 0.29±0.48 and 0 respectively. However these increases were not significant (p=0.60 and p=0.99 respectively). In CT scan population the increased incidence of the chg and the chb were found with a mean±SD frequency of 2.73±0.79 and 2.6±0.91 per 100 cells respectively, while controls had 1.86±0.69 and 1.29±0.48 per 100 cells for chg and chb. The increase was significant for chb (p<0.05) and not significant for chg (p=0.10). Also there was no significant increase for the chrg (p=0.10); but the increased incidence of the chrb was significant (p<0.05) with a mean±SD frequency of 2±0.75 per 100 cells versus 0.86±0.69 per 100 cells for controls. There were no significant increases for fragments (F) and rearrangements (r) (p=0.10, p=0.40, respectively) for CT scan workers versus controls. All types of the chromosome and the chromatid aberrations were higher in the nuclear medicine workers than in the CT scan workers. However they were not significant (Tables 2 and 3). In breakage study the effect of mitomycin-c as a clastogen medium was studied on chromosome and chromatid aberrations. The results revealed no significant changes in spite of a little increase in frequency of chromosome and chromatid aberrations in the exposed personnel versus the controls (Table 3) (p>0.05). Figure 1 shows chg and chb with solid stain technique.
Fig.1
Shapes of chromatid gap (chtg) and chromatid break (chtb) in metaphase with solid stain technique.

Discussion

In the present study, G-banding and solid stain assays were used to evaluate chromosome aberrations in peripheral lymphocytes of 30 occupationally exposed workers in nuclear medicine and CT scan wards compared with 7 individuals as the control group. Also annually effective dose was evaluated in these personnel using film badge. The measured doses were considerably below the permitted levels (20mSv/year). Our study revealed significantly higher chromosome aberrations in nuclear medicine exposed individuals compared with CT scan workers and controls. Nuclear medicine workers milk the generator, inject radionuclides to the patients and take medical images. These activities take a long time and obviously make long term exposures. Chromatid type damages were found higher than chromosome type aberration in the exposed workers and the control group. It is in line with the results reported by Garaj-Vrhorac et al and Hagelstrom et al. It could be due to the low ionizing radiation doses chronically received. However life style and environmental factors are also effective parameters in this subject (9,1). This study showed compared to other damages, fragments and rearrangements (ring, dicentric) had lower incidence in the exposed workers. It is in agreement with the results reported by Francis Maffi et al.[18] Nuclear medicine and CT scan personnel are exposed by low level of chronic X and γ rays leading mostly single strand break. Chromosome translocations need double strand breaks. It could be due to higher level of ionizing radiations. Besides ring and dicentric chromosome damages are unstable and shown as a consequence of an in vitro or an acute in vivo ionizing irradiation. Translocations are stable chromosome aberrations to be accumulated in cells increasing risk of cancers. G-banding did not show any translocation. However it is suggested to do fluorescent in situ hybridization (FISH) for making sure. We could not find correlation between age and chromosome aberrations. It is in agreement with some earlier studies (19,20). However some other studies reported contradictory results (21,22).Instability of chromosome damages could hide the age effect. There was no significant correlation between chromosome damage and gender. It is similar to the results reported by Sari-Minodier et al and Francesca Maffei et al (5,17), and contrary to the results reported by Zakeri et al and Amerunnisa et al (3). History of work experience had no correlation with chromosome damages. It is in agreement with the cytogenetic evaluation on occupationally exposed individuals reported by Monika et al (4). It could be due to instability of chromosome damage and considering radiation safety guidelines and using protection. There was no positive correlation between the effective dose and the redundancy of chromosome aberration in low dose radiation. Some previous studies have revealed these results. Also some studies found, it was difficult to understand a dose-effect relationship for low doses of radiation (23,24).This study did not find any correlation between smoking habit and chromosome aberrations. In this study the culture medium was treated by clastogenic factor of mytocin-c. This factor is used for Fanconi’s anemia diagnosis. We interested to find if it could be a radiosensitizer or not. We found mytocin-c had no radiosensitizer effect.

Conclusion

This study showed that chromosome aberrations in peripheral lymphocytes using solid stain method are reasonable biomarker reflecting personnel radiation damage. Despite the annual effective doses among CT scan and nuclear medicine workers were significantly below the maximum annual occupational dose limit (20mSv/year); their chromosome aberrations redundancies in peripheral lymphocytes were higher than the controls. Therefore cancer risks from low doses of ionizing radiations in those exposed workers are higher than the normal populations. However the issue is complicated due to individuals’ differences in radiosensitivity, general state of the health, nutrition, habit and life style.

Acknowledgments

This study has been supported by Tehran University of Medical Sciences.

Conflict of interests

The authors have no conflicts to disclose.
  23 in total

1.  Assessment of DNA damage in lymphocytes of workers exposed to X-radiation using the micronucleus test and the comet assay.

Authors:  S W Maluf; D F Passos; A Bacelar; G Speit; B Erdtmann
Journal:  Environ Mol Mutagen       Date:  2001       Impact factor: 3.216

2.  Spectrum of chromosomal aberrations in peripheral lymphocytes of hospital workers occupationally exposed to low doses of ionizing radiation.

Authors:  Francesca Maffei; Sabrina Angelini; Giorgio Cantelli Forti; Francesco S Violante; Vittorio Lodi; Stefano Mattioli; Patrizia Hrelia
Journal:  Mutat Res       Date:  2004-03-22       Impact factor: 2.433

3.  The micronucleus assay as a biological dosimeter in hospital workers exposed to low doses of ionizing radiation.

Authors:  Monica Ropolo; Cristina Balia; Paola Roggieri; Vittorio Lodi; Maria Concetta Nucci; Francesco Saverio Violante; Paola Silingardi; Annamaria Colacci; Claudia Bolognesi
Journal:  Mutat Res       Date:  2012-04-14       Impact factor: 2.433

4.  Biological effects of low-dose ionizing radiation exposure on interventional cardiologists.

Authors:  F Zakeri; T Hirobe; K Akbari Noghabi
Journal:  Occup Med (Lond)       Date:  2010-06-02       Impact factor: 1.611

5.  Assessment of DNA damage in nuclear medicine personnel--comparative study with the alkaline comet assay and the chromosome aberration test.

Authors:  Nevenka Kopjar; Vera Garaj-Vrhovac
Journal:  Int J Hyg Environ Health       Date:  2005       Impact factor: 5.840

6.  Evaluation of cytogenetic damage in nuclear medicine personnel occupationally exposed to low-level ionising radiation.

Authors:  Vera Garaj-Vrhovac; Nevenka Kopjar; Mirjana Poropat
Journal:  Arh Hig Rada Toksikol       Date:  2006-03       Impact factor: 1.948

7.  Evaluation of the genotoxic effects of chronic low-dose ionizing radiation exposure on nuclear medicine workers.

Authors:  Ali Sahin; Abdulgani Tatar; Sitki Oztas; Bedri Seven; Erhan Varoglu; Ahmet Yesilyurt; Arif Kursad Ayan
Journal:  Nucl Med Biol       Date:  2009-05-07       Impact factor: 2.408

8.  Maintaining a proper perspective of risk associated with radiation exposure.

Authors:  M A Thompson
Journal:  J Nucl Med Technol       Date:  2001-09

9.  Evaluation of patient and staff doses during various CT fluoroscopy guided interventions.

Authors:  Nico Buls; Jessica Pagés; Johan de Mey; Michel Osteaux
Journal:  Health Phys       Date:  2003-08       Impact factor: 1.316

10.  Micronucleated lymphocytes in people occupationally exposed to potential environmental contaminants: the age effect.

Authors:  L Migliore; M Parrini; I Sbrana; C Biagini; A Battaglia; N Loprieno
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

View more
  1 in total

1.  Exposure Assessment and Biomonitoring of Workers in Magnetic Resonance Environment: An Exploratory Study.

Authors:  Anna Sannino; Stefania Romeo; Maria Rosaria Scarfì; Rita Massa; Raffaele d'Angelo; Antonella Petrillo; Vincenzo Cerciello; Roberta Fusco; Olga Zeni
Journal:  Front Public Health       Date:  2017-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.